In a landmark advancement for women’s cancer research, Dr. Takuma Hayashi and his team have made groundbreaking discoveries that could transform our understanding and treatment of uterine leiomyosarcoma (LMS), one of the most aggressive and treatment-resistant gynecological malignancies….
